Close menu



Pembrolizumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Pembrolizumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Pembrolizumab-like is a recombinant, stable isotope labelled IgG4-Kappa monoclonal antibody containing proteotypic peptides derived from Pembrolizumab’s originator sequence. Labelled Pembrolizumab- like is designed for use as an internal standard for quantitative analysis of Pembrolizumab in plasma samples. Pembrolizumab targets the immune checkpoint programmed death receptor-1 (PD-1) and is used to treat a number of cancers.

This product is for research use only and is not intended for diagnostic or therapeutic use.